CN Stock MarketDetailed Quotes

688253 Innovita Biological Technology

Watchlist
  • 34.86
  • -1.02-2.84%
Market Closed Jul 10 15:00 CST
4.74BMarket Cap17.81P/E (TTM)

Innovita Biological Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-48.69%234.03M
-57.17%166.46M
-66.76%155.97M
-39.17%300.97M
2.32%456.14M
-18.98%388.67M
--469.21M
21.71%494.77M
--445.79M
-0.48%479.74M
Transactional financial assets
62.09%1.58B
37.32%1.53B
35.25%1.33B
777.06%1.15B
613.38%977.73M
1,177.58%1.11B
--983.04M
-1.58%130.95M
--137.06M
-23.64%87.25M
Notes receivable and accounts receivable
-37.44%77.24M
-15.40%105.17M
48.20%105.32M
58.67%111.68M
2,351.51%123.45M
2,910.11%124.31M
--71.06M
646.68%70.38M
--5.04M
-54.38%4.13M
-Accounts receivable
-37.44%77.24M
-15.40%105.17M
48.20%105.32M
58.67%111.68M
2,351.51%123.45M
2,910.11%124.31M
--71.06M
646.68%70.38M
--5.04M
-54.38%4.13M
Other receivables (including interest and dividends)
-34.90%2.55M
-84.17%1.68M
-15.99%3.37M
-51.18%3.18M
-34.85%3.92M
3,878.19%10.63M
--4.01M
1,597.29%6.52M
--6.02M
-96.57%267.23K
-Other receivable
----
-84.17%1.68M
----
--3.18M
----
3,878.19%10.63M
----
----
--6.02M
-96.57%267.23K
Advance payment
-49.03%10.99M
-69.19%7.1M
-78.76%8.42M
-73.24%9.62M
-46.29%21.56M
-23.18%23.04M
--39.62M
36.80%35.95M
--40.13M
5.83%29.99M
Inventories
-10.57%67.14M
-17.76%61.51M
-10.71%42M
-18.04%44.21M
81.20%75.08M
71.44%74.8M
--47.04M
0.76%53.94M
--41.43M
13.44%43.63M
Other current assets
78.91%3.6K
-92.65%104.14K
-43.55%370.66K
-99.16%21.46K
-99.91%2.01K
-49.72%1.42M
--656.61K
8.75%2.56M
--2.2M
862.12%2.82M
Total current assets
19.24%1.98B
7.78%1.87B
1.88%1.65B
103.53%1.62B
144.65%1.66B
168.21%1.74B
--1.61B
25.89%795.09M
--677.66M
-4.76%647.83M
Non Current assets
Other equity investment
-37.81%3.11M
-37.81%3.11M
0.00%5M
0.00%5M
0.00%5M
0.00%5M
--5M
--5M
--5M
--5M
Other non-current financial assets
62.50%13M
62.50%13M
--8M
--8M
--8M
--8M
----
----
----
----
Fixed assets
----
-7.31%115.08M
----
--140.52M
----
7.82%124.15M
----
----
--111.82M
78.61%115.14M
Constru in process
----
----
----
--640.71K
----
----
----
----
--198.11K
-92.00%198.11K
Intangible assets
-3.25%6.96M
-3.22%7.02M
-3.19%7.08M
-3.17%7.14M
-3.14%7.2M
-3.12%7.25M
--7.31M
-3.07%7.37M
--7.43M
114.47%7.49M
Long deferred expense
33.22%14.15M
-28.08%8.65M
96.96%7.53M
79.30%9.31M
83.32%10.62M
64.36%12.02M
--3.82M
-39.54%5.19M
--5.79M
137.59%7.31M
Deferred tax assets
513.32%16.18M
493.95%13.41M
234.49%6.09M
229.32%5.95M
114.48%2.64M
85.11%2.26M
--1.82M
135.42%1.81M
--1.23M
-28.71%1.22M
Usufruct assets
-37.11%3.32M
-46.07%3.31M
-28.64%3.54M
19.07%4.41M
330.01%5.29M
287.23%6.14M
--4.96M
67.62%3.7M
--1.23M
-30.62%1.58M
Other non current assets
106.74%13.32M
-70.47%11.31M
-37.59%11.85M
-32.77%15.1M
-59.92%6.44M
216.65%38.3M
--18.99M
-11.52%22.46M
--16.07M
-50.32%12.1M
Total non current assets
-3.25%200.3M
-5.87%193.04M
25.30%205.2M
33.17%213.65M
39.16%207.04M
36.67%205.07M
--163.77M
11.56%160.43M
--148.77M
47.32%150.05M
Total assets
16.74%2.18B
6.34%2.07B
4.04%1.85B
91.72%1.83B
125.66%1.86B
143.47%1.94B
130.81%1.78B
23.24%955.52M
--826.44M
2.02%797.87M
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
--17.62M
--17.59M
--10.01M
--10.01M
----
Notes payable and accounts payable
8.24%65.15M
-11.17%63.57M
3.49%41.18M
-20.52%41.47M
197.97%60.19M
238.27%71.56M
--39.79M
53.91%52.17M
--20.2M
-44.71%21.16M
-Notes payable
----
----
----
----
----
--2.37M
--2.37M
----
----
----
-Accounts payable
8.24%65.15M
-8.13%63.57M
10.04%41.18M
-20.52%41.47M
197.97%60.19M
227.07%69.19M
--37.42M
53.91%52.17M
--20.2M
-44.71%21.16M
Contract liabilities
190.35%66.33M
-4.23%100.66M
145.08%22.1M
31.78%9.95M
108.26%22.84M
1,682.28%105.1M
--9.02M
287.23%7.55M
--10.97M
-54.43%5.9M
Salaries payable
168.84%20.8M
63.62%20.97M
-5.26%14.82M
7.15%10.15M
12.12%7.74M
-27.93%12.82M
--15.64M
-6.09%9.48M
--6.9M
-22.40%17.78M
Taxs payable
-0.69%14.53M
11.02%20.84M
-81.94%3.03M
-45.03%9.86M
227.65%14.63M
271.51%18.77M
--16.75M
99.46%17.94M
--4.47M
-76.69%5.05M
Other payable (including interest and dividends)
184.58%8.66M
51.57%4.2M
152.04%3.41M
109.27%2.94M
149.69%3.04M
145.43%2.77M
--1.35M
-1.33%1.41M
--1.22M
-67.32%1.13M
-Other payable
----
51.57%4.2M
----
--2.94M
----
145.43%2.77M
----
----
--1.22M
-67.32%1.13M
Non current liabilities due within one year
-49.53%1.62M
-34.98%1.96M
-16.47%2.16M
42.32%2.86M
325.81%3.21M
242.73%3.01M
--2.58M
62.95%2.01M
--752.78K
-4.53%878.72K
Other current liabilities
114.24%2.04M
-73.45%3.04M
141.40%690.74K
46.87%443.92K
142.76%954.17K
4,486.57%11.45M
--286.14K
27.14%302.24K
--393.05K
-65.97%249.68K
Total current liabilities
59.08%179.13M
-11.47%215.23M
-15.17%87.38M
-22.98%77.69M
105.07%112.6M
366.20%243.11M
--103.01M
74.42%100.87M
--54.91M
-52.25%52.15M
Current liabilities
Deferred tax liabilities
98.39%2.66M
96.45%2.58M
--1.63M
5,441.23%1.63M
174,791.79%1.34M
2,781.84%1.31M
----
--29.44K
--766.41
--45.52K
Long term deferred income
-25.53%4.33M
-24.14%4.8M
-26.44%5.06M
-12.92%5.48M
-12.62%5.81M
-9.48%6.33M
--6.88M
87.17%6.29M
--6.65M
85.50%6.99M
Lease liabilities
-29.55%1.41M
-58.33%1.04M
-39.41%1.32M
-7.01%1.48M
466.57%2M
376.64%2.49M
--2.17M
116.29%1.59M
--353.72K
-53.05%521.98K
Total non current liabilities
-8.26%8.4M
-16.92%8.41M
-11.59%8.01M
8.57%8.59M
30.72%9.15M
34.01%10.13M
--9.06M
93.11%7.91M
--7M
54.87%7.56M
Total liabilities
54.01%187.52M
-11.69%223.65M
-14.88%95.39M
-20.69%86.27M
96.66%121.76M
324.16%253.24M
135.04%112.07M
75.66%108.78M
--61.91M
-47.67%59.7M
Shareholders equity
Paid-in capital
0.00%136.06M
0.00%136.06M
0.00%136.06M
33.34%136.06M
33.34%136.06M
33.34%136.06M
--136.06M
0.00%102.04M
--102.04M
0.00%102.04M
Capital reserve funds
0.37%1.03B
0.23%1.02B
0.03%1.02B
299.79%1.02B
299.79%1.02B
299.79%1.02B
--1.02B
0.00%255.67M
--255.67M
0.10%255.67M
Surplus reserve funds
83.85%46.19M
83.85%46.19M
60.26%25.12M
60.26%25.12M
60.26%25.12M
60.26%25.12M
--15.68M
3,339.03%15.68M
--15.68M
3,339.03%15.68M
Retained profit
39.75%782.4M
25.75%636.32M
15.74%569.98M
18.48%560.85M
43.13%559.84M
38.72%506.02M
--492.48M
33.24%473.36M
--391.14M
17.77%364.79M
Other composite income
---960.6K
---1.02M
--1.3M
--1.44M
----
----
----
----
----
----
Shareholders equity without minority interests
14.14%1.99B
9.04%1.84B
5.31%1.75B
106.16%1.75B
128.01%1.74B
128.85%1.69B
--1.67B
18.68%846.74M
--764.52M
10.56%738.17M
Minority interests
----
----
----
----
----
----
----
---335.53
---311.78
----
Total shareholder equity
14.14%1.99B
9.04%1.84B
5.31%1.75B
106.16%1.75B
128.01%1.74B
128.85%1.69B
130.53%1.67B
18.68%846.74M
--764.52M
10.50%738.17M
Total liabilityies and equity
16.74%2.18B
6.34%2.07B
4.04%1.85B
91.72%1.83B
125.66%1.86B
143.47%1.94B
130.81%1.78B
23.24%955.52M
--826.44M
2.02%797.87M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
--
--
--
--
--
Auditor
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -48.69%234.03M-57.17%166.46M-66.76%155.97M-39.17%300.97M2.32%456.14M-18.98%388.67M--469.21M21.71%494.77M--445.79M-0.48%479.74M
Transactional financial assets 62.09%1.58B37.32%1.53B35.25%1.33B777.06%1.15B613.38%977.73M1,177.58%1.11B--983.04M-1.58%130.95M--137.06M-23.64%87.25M
Notes receivable and accounts receivable -37.44%77.24M-15.40%105.17M48.20%105.32M58.67%111.68M2,351.51%123.45M2,910.11%124.31M--71.06M646.68%70.38M--5.04M-54.38%4.13M
-Accounts receivable -37.44%77.24M-15.40%105.17M48.20%105.32M58.67%111.68M2,351.51%123.45M2,910.11%124.31M--71.06M646.68%70.38M--5.04M-54.38%4.13M
Other receivables (including interest and dividends) -34.90%2.55M-84.17%1.68M-15.99%3.37M-51.18%3.18M-34.85%3.92M3,878.19%10.63M--4.01M1,597.29%6.52M--6.02M-96.57%267.23K
-Other receivable -----84.17%1.68M------3.18M----3,878.19%10.63M----------6.02M-96.57%267.23K
Advance payment -49.03%10.99M-69.19%7.1M-78.76%8.42M-73.24%9.62M-46.29%21.56M-23.18%23.04M--39.62M36.80%35.95M--40.13M5.83%29.99M
Inventories -10.57%67.14M-17.76%61.51M-10.71%42M-18.04%44.21M81.20%75.08M71.44%74.8M--47.04M0.76%53.94M--41.43M13.44%43.63M
Other current assets 78.91%3.6K-92.65%104.14K-43.55%370.66K-99.16%21.46K-99.91%2.01K-49.72%1.42M--656.61K8.75%2.56M--2.2M862.12%2.82M
Total current assets 19.24%1.98B7.78%1.87B1.88%1.65B103.53%1.62B144.65%1.66B168.21%1.74B--1.61B25.89%795.09M--677.66M-4.76%647.83M
Non Current assets
Other equity investment -37.81%3.11M-37.81%3.11M0.00%5M0.00%5M0.00%5M0.00%5M--5M--5M--5M--5M
Other non-current financial assets 62.50%13M62.50%13M--8M--8M--8M--8M----------------
Fixed assets -----7.31%115.08M------140.52M----7.82%124.15M----------111.82M78.61%115.14M
Constru in process --------------640.71K------------------198.11K-92.00%198.11K
Intangible assets -3.25%6.96M-3.22%7.02M-3.19%7.08M-3.17%7.14M-3.14%7.2M-3.12%7.25M--7.31M-3.07%7.37M--7.43M114.47%7.49M
Long deferred expense 33.22%14.15M-28.08%8.65M96.96%7.53M79.30%9.31M83.32%10.62M64.36%12.02M--3.82M-39.54%5.19M--5.79M137.59%7.31M
Deferred tax assets 513.32%16.18M493.95%13.41M234.49%6.09M229.32%5.95M114.48%2.64M85.11%2.26M--1.82M135.42%1.81M--1.23M-28.71%1.22M
Usufruct assets -37.11%3.32M-46.07%3.31M-28.64%3.54M19.07%4.41M330.01%5.29M287.23%6.14M--4.96M67.62%3.7M--1.23M-30.62%1.58M
Other non current assets 106.74%13.32M-70.47%11.31M-37.59%11.85M-32.77%15.1M-59.92%6.44M216.65%38.3M--18.99M-11.52%22.46M--16.07M-50.32%12.1M
Total non current assets -3.25%200.3M-5.87%193.04M25.30%205.2M33.17%213.65M39.16%207.04M36.67%205.07M--163.77M11.56%160.43M--148.77M47.32%150.05M
Total assets 16.74%2.18B6.34%2.07B4.04%1.85B91.72%1.83B125.66%1.86B143.47%1.94B130.81%1.78B23.24%955.52M--826.44M2.02%797.87M
Liabilities
Current liabilities
Short term loan ----------------------17.62M--17.59M--10.01M--10.01M----
Notes payable and accounts payable 8.24%65.15M-11.17%63.57M3.49%41.18M-20.52%41.47M197.97%60.19M238.27%71.56M--39.79M53.91%52.17M--20.2M-44.71%21.16M
-Notes payable ----------------------2.37M--2.37M------------
-Accounts payable 8.24%65.15M-8.13%63.57M10.04%41.18M-20.52%41.47M197.97%60.19M227.07%69.19M--37.42M53.91%52.17M--20.2M-44.71%21.16M
Contract liabilities 190.35%66.33M-4.23%100.66M145.08%22.1M31.78%9.95M108.26%22.84M1,682.28%105.1M--9.02M287.23%7.55M--10.97M-54.43%5.9M
Salaries payable 168.84%20.8M63.62%20.97M-5.26%14.82M7.15%10.15M12.12%7.74M-27.93%12.82M--15.64M-6.09%9.48M--6.9M-22.40%17.78M
Taxs payable -0.69%14.53M11.02%20.84M-81.94%3.03M-45.03%9.86M227.65%14.63M271.51%18.77M--16.75M99.46%17.94M--4.47M-76.69%5.05M
Other payable (including interest and dividends) 184.58%8.66M51.57%4.2M152.04%3.41M109.27%2.94M149.69%3.04M145.43%2.77M--1.35M-1.33%1.41M--1.22M-67.32%1.13M
-Other payable ----51.57%4.2M------2.94M----145.43%2.77M----------1.22M-67.32%1.13M
Non current liabilities due within one year -49.53%1.62M-34.98%1.96M-16.47%2.16M42.32%2.86M325.81%3.21M242.73%3.01M--2.58M62.95%2.01M--752.78K-4.53%878.72K
Other current liabilities 114.24%2.04M-73.45%3.04M141.40%690.74K46.87%443.92K142.76%954.17K4,486.57%11.45M--286.14K27.14%302.24K--393.05K-65.97%249.68K
Total current liabilities 59.08%179.13M-11.47%215.23M-15.17%87.38M-22.98%77.69M105.07%112.6M366.20%243.11M--103.01M74.42%100.87M--54.91M-52.25%52.15M
Current liabilities
Deferred tax liabilities 98.39%2.66M96.45%2.58M--1.63M5,441.23%1.63M174,791.79%1.34M2,781.84%1.31M------29.44K--766.41--45.52K
Long term deferred income -25.53%4.33M-24.14%4.8M-26.44%5.06M-12.92%5.48M-12.62%5.81M-9.48%6.33M--6.88M87.17%6.29M--6.65M85.50%6.99M
Lease liabilities -29.55%1.41M-58.33%1.04M-39.41%1.32M-7.01%1.48M466.57%2M376.64%2.49M--2.17M116.29%1.59M--353.72K-53.05%521.98K
Total non current liabilities -8.26%8.4M-16.92%8.41M-11.59%8.01M8.57%8.59M30.72%9.15M34.01%10.13M--9.06M93.11%7.91M--7M54.87%7.56M
Total liabilities 54.01%187.52M-11.69%223.65M-14.88%95.39M-20.69%86.27M96.66%121.76M324.16%253.24M135.04%112.07M75.66%108.78M--61.91M-47.67%59.7M
Shareholders equity
Paid-in capital 0.00%136.06M0.00%136.06M0.00%136.06M33.34%136.06M33.34%136.06M33.34%136.06M--136.06M0.00%102.04M--102.04M0.00%102.04M
Capital reserve funds 0.37%1.03B0.23%1.02B0.03%1.02B299.79%1.02B299.79%1.02B299.79%1.02B--1.02B0.00%255.67M--255.67M0.10%255.67M
Surplus reserve funds 83.85%46.19M83.85%46.19M60.26%25.12M60.26%25.12M60.26%25.12M60.26%25.12M--15.68M3,339.03%15.68M--15.68M3,339.03%15.68M
Retained profit 39.75%782.4M25.75%636.32M15.74%569.98M18.48%560.85M43.13%559.84M38.72%506.02M--492.48M33.24%473.36M--391.14M17.77%364.79M
Other composite income ---960.6K---1.02M--1.3M--1.44M------------------------
Shareholders equity without minority interests 14.14%1.99B9.04%1.84B5.31%1.75B106.16%1.75B128.01%1.74B128.85%1.69B--1.67B18.68%846.74M--764.52M10.56%738.17M
Minority interests -------------------------------335.53---311.78----
Total shareholder equity 14.14%1.99B9.04%1.84B5.31%1.75B106.16%1.75B128.01%1.74B128.85%1.69B130.53%1.67B18.68%846.74M--764.52M10.50%738.17M
Total liabilityies and equity 16.74%2.18B6.34%2.07B4.04%1.85B91.72%1.83B125.66%1.86B143.47%1.94B130.81%1.78B23.24%955.52M--826.44M2.02%797.87M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion----------------
Auditor --Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg